Britain’s drug regulator suspends hydroxychloroquine trial recruitment

Britain’s drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.

Leave a Reply

Your email address will not be published. Required fields are marked *